Wiki

Wiki Lint Report — 2026-05-06

Wiki Lint Report — 2026-05-06

Scope: ~127 pages audited.
Result: 3 auto-fixes applied. 15 flags raised (5 clinical, 6 documentation, 4 structural).


Auto-Fixes Applied

# File Fix
1 Pancytopenia status: active → resolved; date_resolved: 2026-05-04
2 Hyponatremia status: active → resolved; date_resolved: 2026-05-04; May 4 row (Na 142, Cl 103) appended
3 Imaging Timeline Populated with 3 existing studies (ABI Doppler, Biothesiometry, Monofilament — 2022-11-25)

Clinical / Safety Flags 🔴

1. BP Completely Undocumented

  • On Losartan monotherapy; Nifedipine not being taken
  • HTN diagnosis presumed — zero BP readings in vault
  • Action: Obtain at next clinic visit

2. Falls Risk Assessment Absent

  • Age 81 + Pregabalin 75 mg + residual anemia (Hb 11.9) + biothesiometry VPT 29–33V (moderate neuropathy, 2022)
  • No TUG or equivalent documented
  • Action: Request formal falls assessment from treating team

3. Fructosamine Recheck Due ~May 20

  • Last: 310 µmol/L (HIGH, 2026-04-22). 4–6 wk interval applies
  • HbA1c unreliable in AML; fructosamine is the only valid glycemic marker
  • See Fructosamine, Diabetes Mellitus

4. Cr/eGFR Overdue

  • Last: 0.6 mg/dL on 2026-04-06 (30 days ago)
  • Metformin safety + Losartan monitoring both require periodic renal function check
  • Action: Include Cr on next lab draw

5. Prednisolone Indication Never Documented

  • 15-day course prescribed 2026-05-04; patient confirmed not taking it
  • Indication field remains "Unknown" — documentation failure for the record

Documentation Flags 🟡

6. Oncology Drug Doses Unknown

7. 64% of Medication Prescribers Unknown

  • 14 of 22 medication pages have no prescriber
  • Jothydev's DM meds should be attributable to Jothydev Kesavadev

8. No Formal DPN Diagnosis Page

  • Pregabalin indication: "presumed diabetic neuropathy"
  • Biothesiometry (2022) confirms subclinical DPN — sufficient to create a formal condition page
  • Action: Create conditions/diabetic-peripheral-neuropathy.md

9. Serratiopeptidase Indication and Frequency Unknown

  • Role in AML context unclear
  • Action: Ask prescriber or check pharmacy label

10. Insulin Switch (Glargine → Degludec) Undocumented

  • When and why the transition occurred is unrecorded
  • Action: Obtain insulin Rx history from Jothydev's clinic or pharmacy

11. Cycle 5 Scheduling Absent

  • No appointment letter or Cycle 5 clinic note in vault
  • Estimated window May 4–17; ANC cleared (2360, May 4)
  • Action: Drop scheduling letter or next clinic note into raw/clinic-notes/ and run /ingest

Structural Flags ℹ️

12. jothydev-clinic-note-2022-11-25.md Misclassified

  • File has type: condition but content is a clinic visit note
  • Action: Change type field to type: clinic-note

13. wiki/_jobs/ Directory Undeclared

  • Directory exists but is not defined in the CLAUDE.md schema
  • Action: Either add to schema or confirm it is ephemeral/safe to remove

14. wiki/summaries/ Directory Empty

  • No new-provider-packet, medication reconciliation, or surgical history summary generated yet
  • Action: Run /new-provider or /med-rec to populate

15. wiki/overview.md Stale updated: Field

  • Body references May 4 data but frontmatter updated: has not been changed
  • Action: Set updated: 2026-05-04

Clean Checks ✅

Check Result
Broken wikilinks 0
Missing schema directories 0
Orphan pages 0
Frontmatter structure violations 0 (all 127 pages valid)

Priority Order for Human Follow-Up

  1. Fructosamine recheck — ~May 20 (time-sensitive)
  2. Cr/eGFR on next draw — metformin safety
  3. BP measurement at next visit — HTN management blind
  4. Create DPN condition page — enables proper duloxetine/pregabalin documentation
  5. Obtain oncology prescription PDFs — resolves 6 dose gaps
  6. Falls assessment — age + polypharmacy risk